Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
bristol-myers squibb
clinical trials
2
×
intercept pharmaceuticals
life sciences
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
2
×
san diego blog main
san diego top stories
2
×
san francisco blog main
san francisco top stories
4d molecular therapeutics
abbvie
acne
agenus
allergan
astrazeneca
auris health
avexis
bayer
biomx
biotech
bladder cancer
boulder/denver blog main
boulder/denver top stories
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
celgene
centers for medicare and medicaid services
clinical data
deals
detroit blog main
What
approved
disease
2
×
drug
2
×
fatty
known
liver
nash
2
×
bio
companies
data
digital
epidemic
fda
frenzied
growing
horizon
intercept
led
marketed
medicine
merck
new
news
nonalcoholic
race
roundup
steatohepatitis
strikes
tokens
track
treatment
Language
Current search:
disease
×
drug
×
" clinical trials "
×
nash
×
" san diego top stories "
×
" obeticholic acid "
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug